{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:59:13Z","timestamp":1791838753067,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Boehringer Ingelheim supported the publication of this article, including the journal\u2019s Rapid Service and Open Access Fees."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s13555-022-00881-0","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T21:02:30Z","timestamp":1673557350000},"page":"673-688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4604-0724","authenticated-orcid":false,"given":"Raquel","family":"Rivera-D\u00edaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Daud\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Carrascosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo de la","family":"Cueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"issue":"3","key":"881_CR1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s13555-021-00518-8","volume":"11","author":"KA Papp","year":"2021","unstructured":"Papp KA, Gniadecki R, Beecker J, et al. Psoriasis prevalence and severity by expert elicitation. Dermatol Ther (Heidelb). 2021;11(3):1053\u201364.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"881_CR2","volume-title":"Global report on Psoriasis","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Global report on Psoriasis. Geneva: World Health Organization; 2016."},{"issue":"9997","key":"881_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP. Psoriasis. Lancet. 2015;386(9997):983\u201394.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"881_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40257-021-00654-z","volume":"23","author":"SE Choon","year":"2022","unstructured":"Choon SE, Navarini AA, Pinter A. Clinical course and characteristics of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):21\u20139.","journal-title":"Am J Clin Dermatol"},{"issue":"11","key":"881_CR5","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1111\/jdv.14386","volume":"31","author":"AA Navarini","year":"2017","unstructured":"Navarini AA, Burden AD, Capon F, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31(11):1792\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"881_CR6","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/1346-8138.14523","volume":"45","author":"H Fujita","year":"2018","unstructured":"Fujita H, Terui T, Hayama K, et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP. J Dermatol. 2018;45(11):1235\u201370.","journal-title":"J Dermatol"},{"issue":"Suppl 1","key":"881_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40257-021-00652-1","volume":"23","author":"H Fujita","year":"2022","unstructured":"Fujita H, Gooderham M, Romiti R. Diagnosis of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):31\u20138.","journal-title":"Am J Clin Dermatol"},{"key":"881_CR8","first-page":"37","volume":"9","author":"K Ly","year":"2019","unstructured":"Ly K, Beck KM, Smith MP, Thibodeaux Q, Bhutani T. Diagnosis and screening of patients with generalized pustular psoriasis. Psoriasis (Auckl). 2019;9:37\u201342.","journal-title":"Psoriasis (Auckl)"},{"issue":"Suppl 1","key":"881_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40257-021-00664-x","volume":"23","author":"M Zheng","year":"2022","unstructured":"Zheng M, Jullien D, Eyerich K. The prevalence and disease characteristics of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):5\u201312.","journal-title":"Am J Clin Dermatol."},{"issue":"9","key":"881_CR10","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/1744666X.2019.1648209","volume":"15","author":"MJ Gooderham","year":"2019","unstructured":"Gooderham MJ, Van Voorhees AS, Lebwohl MG. An update on generalized pustular psoriasis. Expert Rev Clin Immunol. 2019;15(9):907\u201319.","journal-title":"Expert Rev Clin Immunol"},{"issue":"2 Suppl","key":"881_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.12788\/cutis.0579","volume":"110","author":"KA Reynolds","year":"2022","unstructured":"Reynolds KA, Pithadia DJ, Lee EB, Clarey D, Liao W, Wu JJ. Generalized pustular psoriasis: a review of the pathophysiology, clinical manifestations, diagnosis, and treatment. Cutis. 2022;110(2 Suppl):19\u201325.","journal-title":"Cutis"},{"issue":"10","key":"881_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/1744666X.2022.2116003","volume":"18","author":"H Bachelez","year":"2022","unstructured":"Bachelez H, Barker J, Burden AD, Navarini AA, Krueger JG. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion. Expert Rev Clin Immunol. 2022;18(10):1033\u201347.","journal-title":"Expert Rev Clin Immunol"},{"key":"881_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/1744666X.2019.1708193","volume":"16","author":"S Kharawala","year":"2020","unstructured":"Kharawala S, Golembesky AK, Bohn RL, Esser D. The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review. Expert Rev Clin Immunol. 2020;16:239\u201352.","journal-title":"Expert Rev Clin Immunol"},{"key":"881_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.5021\/ad.2017.29.6.761","volume":"29","author":"JY Lee","year":"2017","unstructured":"Lee JY, Kang S, Park JS, et al. Prevalence of psoriasis in Korea: a population-based epidemiological study using the Korean National Health Insurance Database. Ann Dermatol. 2017;29:761\u20137.","journal-title":"Ann Dermatol"},{"key":"881_CR15","doi-asserted-by":"crossref","unstructured":"L\u00f6fvendahl S, Norlin JM, Schmitt-Egenolf M. Prevalence and incidence of generalised pustular psoriasis in Sweden - a population-based register study. Br J Dermatol. 2022.","DOI":"10.2147\/PTT.S359011"},{"issue":"Suppl 1","key":"881_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40257-021-00655-y","volume":"23","author":"S Marrakchi","year":"2022","unstructured":"Marrakchi S, Puig L. Pathophysiology of generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):13\u20139.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"881_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3892\/ijmm.2021.4951","volume":"47","author":"J Zhou","year":"2021","unstructured":"Zhou J, Luo Q, Cheng Y, Wen X, Liu J. An update on genetic basis of generalized pustular psoriasis (Review). Int J Mol Med. 2021;47(6):118.","journal-title":"Int J Mol Med"},{"key":"881_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16609","author":"A Morita","year":"2022","unstructured":"Morita A, Tsai TF, Yee EYW, et al. Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil\u2122 1 study. J Dermatol. 2022. https:\/\/doi.org\/10.1111\/1346-8138.16609.","journal-title":"J Dermatol"},{"issue":"45","key":"881_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023068","volume":"99","author":"ZJ Liu","year":"2020","unstructured":"Liu ZJ, Tian YT, Shi BY, Zhou Y, Jia XS. Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2020;99(45): e23068.","journal-title":"Medicine (Baltimore)"},{"key":"881_CR20","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/bjd.14954","volume":"176","author":"PA von dem Borne","year":"2017","unstructured":"von dem Borne PA, Jonkman MF, van Doorn R. Complete remission of skin lesions in a patient with subcorneal pustular dermatosis (Sneddon\u2013Wilkinson disease) treated with antimyeloma therapy: association with disappearance of M-protein. Br J Dermatol. 2017;176:1341.","journal-title":"Br J Dermatol"},{"issue":"5","key":"881_CR21","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1684\/ejd.2021.4047","volume":"31","author":"H Wang","year":"2021","unstructured":"Wang H, Jin H. Update on the aetiology and mechanisms of generalized pustular psoriasis. Eur J Dermatol. 2021;31(5):602\u20138.","journal-title":"Eur J Dermatol"},{"issue":"2","key":"881_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s13555-021-00677-8","volume":"12","author":"K Sugiura","year":"2022","unstructured":"Sugiura K. Role of interleukin 36 in generalised pustular psoriasis and beyond. Dermatol Ther (Heidelb). 2022;12(2):315\u201328.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"881_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jaci.2016.08.056","volume":"140","author":"A Johnston","year":"2017","unstructured":"Johnston A, Xing X, Wolterink L, et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017;140(1):109\u201320.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"881_CR24","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3390\/ijms20061257","volume":"20","author":"MA Boutet","year":"2019","unstructured":"Boutet MA, Nerviani A, Pitzalis C. IL-36, IL-37, and IL-38 cytokines in skin and joint inflammation: a comprehensive review of their therapeutic potential. Int J Mol Sci. 2019;20(6):1257.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"881_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/imr.12610","volume":"281","author":"EY Bassoy","year":"2018","unstructured":"Bassoy EY, Towne JE, Gabay C. Regulation and function of interleukin-36 cytokines. Immunol Rev. 2018;281(1):169\u201378.","journal-title":"Immunol Rev"},{"issue":"2","key":"881_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/1744666X.2021.1886081","volume":"17","author":"H Iznardo","year":"2021","unstructured":"Iznardo H, Puig L. The interleukin-1 family cytokines in psoriasis: pathogenetic role and therapeutic perspectives. Expert Rev Clin Immunol. 2021;17(2):187\u201399.","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"881_CR27","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/bjd.15867","volume":"178","author":"R Mossner","year":"2018","unstructured":"Mossner R, Wilsmann-Theis D, Oji V, Gkogkolou P, Lohr S, Schulz P, et al. The genetic basis for most patients with pustular skin disease remains elusive. Br J Dermatol. 2018;178(3):740\u20138.","journal-title":"Br J Dermatol"},{"issue":"1","key":"881_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.abd.2021.05.011","volume":"97","author":"R Romiti","year":"2022","unstructured":"Romiti R, Hirayama ALDS, Arnone M, Magalh\u00e3es RF. Generalized pustular psoriasis (von Zumbusch). An Bras Dermatol. 2022;97(1):63\u201374.","journal-title":"An Bras Dermatol"},{"issue":"7","key":"881_CR29","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.jid.2019.11.024","volume":"140","author":"S Frey","year":"2020","unstructured":"Frey S, Sticht H, Wilsmann-Theis D, et al. Rare loss-of-function mutation in SERPINA3 in generalized pustular psoriasis. J Invest Dermatol. 2020;140(7):1451-5.e13.","journal-title":"J Invest Dermatol"},{"key":"881_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ajhg.2020.07.001","volume":"107","author":"S Haskamp","year":"2020","unstructured":"Haskamp S, Bruns H, Hahn M, et al. Myeloperoxidase modulates inflammation in generalized pustular psoriasis and additional rare pustular skin diseases. Am J Hum Genet. 2020;107:527\u201338.","journal-title":"Am J Hum Genet"},{"key":"881_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ajhg.2020.06.020","volume":"107","author":"M Vergnano","year":"2020","unstructured":"Vergnano M, Mockenhaupt M, Benzian-Olsson N, et al. Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin disease [published correction in Am J Hum Genet 2021;108:757]. Am J Hum Genet. 2020;107:539\u201343.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"881_CR32","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.jid.2021.12.021","volume":"142","author":"S Haskamp","year":"2022","unstructured":"Haskamp S, Frey B, Becker I, et al. Transcriptomes of MPO-deficient patients with generalized pustular psoriasis reveals expansion of CD4+ cytotoxic T cells and an involvement of the complement system. J Invest Dermatol. 2022;142(8):2149-2158.e10.","journal-title":"J Invest Dermatol"},{"issue":"Suppl 1","key":"881_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40257-021-00653-0","volume":"23","author":"AD Burden","year":"2022","unstructured":"Burden AD, Choon SE, Gottlieb AB, Navarini AA, Warren RB. Clinical disease measures in generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):39\u201350.","journal-title":"Am J Clin Dermatol"},{"key":"881_CR34","unstructured":"Choon SE, et al. AAD VMX; April 23\u201325, 2021; Virtual Meeting. https:\/\/www.psoriasiscouncil.org\/docs\/2021_esdr_congress_report.pdf. Accessed 15 May 2022."},{"issue":"Suppl 1","key":"881_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40257-021-00658-9","volume":"23","author":"J Krueger","year":"2022","unstructured":"Krueger J, Puig L, Tha\u00e7i D. Treatment options and goals for patients with generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):51\u201364.","journal-title":"Am J Clin Dermatol"},{"key":"881_CR36","doi-asserted-by":"crossref","unstructured":"Carrascosa JM, Puig L, Belinch\u00f3n Romero I, et al. Practical update of the recommendations published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the treatment of psoriasis with biologic therapy. Actas Dermo-Sifiliogr\u00e1ficas. 2022; 113(3).","DOI":"10.1016\/j.ad.2021.10.011"},{"issue":"5","key":"881_CR37","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/09546634.2019.1682502","volume":"32","author":"DG Kearns","year":"2021","unstructured":"Kearns DG, Chat VS, Zang PD, Han G, Wu JJ. Review of treatments for generalized pustular psoriasis. J Dermatol Treat. 2021;32(5):492\u20134.","journal-title":"J Dermatol Treat"},{"issue":"2","key":"881_CR38","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13555-021-00493-0","volume":"11","author":"B Strober","year":"2021","unstructured":"Strober B, Kotowsky N, Medeiros R, et al. Unmet medical needs in the treatment and management of generalized pustular psoriasis flares: evidence from a survey of Corrona Registry Dermatologists. Dermatol Ther (Heidelb). 2021;11(2):529\u201341.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"881_CR39","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1365-4632.2004.02519.x","volume":"44","author":"H Tamiya","year":"2005","unstructured":"Tamiya H, Fukai K, Moriwaki K, Ishii M. Generalized pustular psoriasis precipitated by topical calcipotriol ointment. Int J Dermatol. 2005;44:791\u20132.","journal-title":"Int J Dermatol"},{"key":"881_CR40","unstructured":"van de Kerkhof PC. From empirical to pathogenesis-based treatments for psoriasis. J Invest Dermatol. 2022:S0022-202X(22)00082\u20133."},{"issue":"21","key":"881_CR41","first-page":"01554","volume":"S0091\u20136749","author":"P Baum","year":"2021","unstructured":"Baum P, Visvanathan S, Garcet S, et al. Pustular psoriasis: molecular pathways and effects of spesolimab in generalized pustular psoriasis. J Allergy Clin Immunol. 2021;S0091\u20136749(21):01554\u201362.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"881_CR42","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.jaci.2021.09.035","volume":"149","author":"P Baum","year":"2022","unstructured":"Baum P, Visvanathan S, Garcet S, et al. Pustular psoriasis: molecular pathways and effects of spesolimab in generalized pustular psoriasis. J Allergy Clin Immunol. 2022;149(4):1402\u201312.","journal-title":"J Allergy Clin Immunol"},{"issue":"26","key":"881_CR43","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa2111563","volume":"385","author":"H Bachelez","year":"2021","unstructured":"Bachelez H, Choon SE, Marrakchi S, et al. Trial of spesolimab for generalized pustular psoriasis. N Engl J Med. 2021;385(26):2431\u201340.","journal-title":"N Engl J Med."},{"key":"881_CR44","unstructured":"ClinicalTrials.gov Identifier: NCT03619902. A study to evaluate the efficacy and safety of imsidolimab (ANB019) in adults with generalized pustular psoriasis (GPP). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03619902. Accessed 17 May 2002."},{"key":"881_CR45","unstructured":"Puig L, Fujita H, Tha\u00e7i D, et al. 30th European Academy of Dermatology and Venereology Congress (29 September \u2013 2 October 2021, Virtual). EADV 2021, p. 1055."},{"key":"881_CR46","unstructured":"Arag\u00f3n Miguel R, SahuquilloTorralba A, Ara Martin M, et al. Psoriasis pustulosas generalizadas y localizadas: estudio multic\u00e9ntrico con 119 pacientes. 7\u00ba Congreso de Psoriasis, Presencial+Virtual, Madrid, Jan 21\u201322, 2022."},{"issue":"1","key":"881_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12969-019-0338-1","volume":"17","author":"T Hospach","year":"2019","unstructured":"Hospach T, Glowatzki F, Blankenburg F, et al. Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents. Pediatr Rheumatol Online J. 2019;17(1):37.","journal-title":"Pediatr Rheumatol Online J"},{"key":"881_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16551","author":"C Miao","year":"2022","unstructured":"Miao C, Chen Y, Wang Z, Xiang X, Liu Y, Xu Z. Real-world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis. J Dermatol. 2022. https:\/\/doi.org\/10.1111\/1346-8138.16551.","journal-title":"J Dermatol"},{"issue":"10","key":"881_CR49","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/medicina57101004","volume":"57","author":"M Sussman","year":"2021","unstructured":"Sussman M, Napodano A, Huang S, Are A, Hsu S, Motaparthi K. Pustular psoriasis and acute generalized exanthematous pustulosis. Medicina (Kaunas). 2021;57(10):1004.","journal-title":"Medicina (Kaunas)"},{"issue":"5","key":"881_CR50","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jaad.2015.07.017","volume":"73","author":"J Szatkowski","year":"2015","unstructured":"Szatkowski J, Schwartz RA. Acute generalized exanthematous pustulosis (AGEP): a review and update. J Am Acad Dermatol. 2015;73(5):843\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"881_CR51","unstructured":"Shadi Kourosh A. Subcorneal pustular dermatosis. https:\/\/www.uptodate.com\/contents\/subcorneal-pustular-dermatosis."},{"issue":"11","key":"881_CR52","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1111\/jocd.14508","volume":"20","author":"R Miladi","year":"2021","unstructured":"Miladi R, Janbakhsh A, Babazadeh A, et al. Pustular psoriasis flare-up in a patient with COVID-19. J Cosmet Dermatol. 2021;20(11):3364\u20138.","journal-title":"J Cosmet Dermatol"},{"key":"881_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdcr.2021.08.035","volume":"17","author":"D Perna","year":"2021","unstructured":"Perna D, Jones J, Schadt CR. Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine. JAAD Case Rep. 2021;17:1\u20133.","journal-title":"JAAD Case Rep"},{"issue":"1","key":"881_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/ced.14895","volume":"47","author":"S Elamin","year":"2022","unstructured":"Elamin S, Hinds F, Tolland J. De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine. Clin Exp Dermatol. 2022;47(1):153\u20135.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"881_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14595","volume":"34","author":"M Shahidi Dadras","year":"2021","unstructured":"Shahidi Dadras M, Diab R, Ahadi M, Abdollahimajd F. Generalized pustular psoriasis following COVID-19. Dermatol Ther. 2021;34(1): e14595.","journal-title":"Dermatol Ther"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00881-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00881-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00881-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T23:45:06Z","timestamp":1677887106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00881-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["881"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00881-0","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"19 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}